New drug trial for Hard-to-Treat leukemia shows early promise
Disease control
Terminated
This study tested an experimental drug called NMS-03592088 in adults with acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) that had come back or stopped responding to standard treatments. The goal was to find the safest dose and see if the drug could help co…
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 15, 2026 11:57 UTC